>
pdufa.bio

AGMB-129

Updated ยทnext FDA decision on the calendar

AGMB-129 is a Agomab Therapeutics NV program. Every date links its source.

AGMB catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Agomab Therapeutics NV (AGMB). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026AGMB

Questions

When is AGMB-129's next FDA decision or readout?

No upcoming catalyst is on our calendar for AGMB-129; no FDA decisions are on record below.

What happened at AGMB-129's most recent FDA decision?

No FDA decision for AGMB-129 is in our archive yet.

Who makes AGMB-129?

Agomab Therapeutics NV (AGMB).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.